Financial Daily from THE HINDU group of publications
Saturday, May 08, 2004

Cross Currency

Group Sites

Home Page - Pharmaceuticals
Corporate - Mergers & Acquisitions

Templeton Strategic buys 2.9 pc stake in Aurobindo Pharma

Our Bureau

Hyderabad , May 7

TEMPLETON Strategic Emerging Markets LDC has acquired 13,05,460 equity shares amounting to 2.9 per cent of the total paid-up capital of Aurobindo Pharma Ltd (APL).

The mode of acquisition of the shares was through the open market and was completed on a single day on April 30, 2004, Templeton Strategic informed the National Stock Exchange on Friday. The shareholding of Templeton Strategic Emerging Markets after this acquisition stands at 36,79,596 equity shares amounting to 7.9131 per cent of the total paid-up capital of APL.

The APL board had allotted one million equity shares and equal number of share warrants to Templeton Strategic in April 2002. In addition to Templeton Strategic, other major foreign institutional investors (FIIs) in APL are ABN Amro Funds and Copthall Mauritius Investment Ltd.

More Stories on : Pharmaceuticals | Mergers & Acquisitions

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Bharti, Reliance lead in mobile user base

Bangalore-bound, but still inside Intel
Post-poll, no major hike in petrol, diesel prices likely
Templeton Strategic buys 2.9 pc stake in Aurobindo Pharma
Polls shadow markets; Sensex down 87 points
Steel subsidy pact not acceptable, OECD told
Ministry exploring ways to encash FM cos' guarantees
Chemplast Sanmar duo wins Business Line Quiz

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line